Paper9852946
A new membrane-bound OprI lipoprotein expression vector. High production of heterologous fusion proteins in gram (-) bacteria and the implications for oral vaccination.
Cote-Sierra J and 7 others. Gene, 1998. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. A new membrane-bound OprI lipoprotein expression vector. High production of heterologous fusion proteins in gram (-) bacteria and the implications for oral vaccination. Papers, record 9852946. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9852946
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A new membrane-bound OprI lipoprotein expression vector. High production of heterologous fusion proteins in gram (-) bacteria and the implications for oral vaccination.
- PubMed
Topics29
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacterial Proteins | Major topic |
| Capsid Proteins | Major topic |
| Escherichia coli Proteins | Major topic |
| Genetic Vectors | Major topic |
| Gram-Negative Bacteria | Major topic |
| Lipoproteins | Major topic |
| Protozoan Proteins | Major topic |
| Vaccines, Synthetic | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Antigens, Protozoan | |
| Antigens, Surface | |
| Base Sequence | |
| Biological Transport | |
| Capsid | |
| Cell Division | |
| Cloning, Molecular | |
| Escherichia coli | |
| Gene Expression Regulation, Bacterial | |
| Isopropyl Thiogalactoside | |
| Lac Repressors | |
| Leishmania major | |
| Molecular Sequence Data | |
| Peptide Fragments | |
| Plasmids | |
| Promoter Regions, Genetic | |
| Recombinant Fusion Proteins | |
| Repressor Proteins | |
| Salmonella typhimurium |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26176321 | Challenges in the production of itaconic acid by metabolically engineered Escherichia coli. | Bioengineered | 2015 | https://conductscience.org/library/papers/26176321 | PubMed |
| 20100832 | Outer membrane protein I of Pseudomonas aeruginosa is a target of cationic antimicrobial peptide/protein. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20100832 | PubMed |
| 19442264 | Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli. | Microb Cell Fact | 2009 | https://conductscience.org/library/papers/19442264 | PubMed |
| 11823186 | Novel bacterial membrane surface display system using cell wall-less L-forms of Proteus mirabilis and Escherichia coli. | Appl Environ Microbiol | 2002 | https://conductscience.org/library/papers/11823186 | PubMed |
| 11748189 | Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major. | Infect Immun | 2002 | https://conductscience.org/library/papers/11748189 | PubMed |
| 10816482 | Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. | Infect Immun | 2000 | https://conductscience.org/library/papers/10816482 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9852946
GET https://conductscience.org/api/papers/v1/9852946/authors